HK inno.N Launches GERD Drug 'K-CAB' in Six Latin American Countries
HK inno.N Corp. has announced the launch of its new gastroesophageal reflux disease (GERD) drug, "K-CAB," in six Latin American countries, marking a significant milestone in the company's global expansion strategy. The launch, completed on …